Merck Animal Health has agreed to acquire TARGAN, a North Carolina poultry technology company backed by Merck since 2017, in a deal that extends the drugmaker’s reach from vaccines into the mechanics of hatchery operations. Terms were not disclosed, and the transaction is expected to close in the third quarter of 2026 pending regulatory approvals.
TARGAN’s value sits in two pieces of infrastructure that touch the earliest and most operationally sensitive stage of poultry production. Its WingScan system uses machine vision to sort chicks by sex at speeds of up to 160,000 birds per hour. Its ocular spray platform delivers vaccines to day-old chicks at industrial scale. Put together, those tools give Merck a way to embed its biologics portfolio directly into customer workflow rather than competing only on the merits of the vaccine itself.
That matters in poultry, where margins are thin, labor is volatile, and producers increasingly want throughput, consistency, and traceability from the same vendor. Merck is not just buying a device company. It is buying a distribution architecture for its poultry franchise and a stronger claim on hatchery budgets. If vaccine administration becomes bundled with automated handling and imaging, switching costs rise.
The acquisition also reflects a broader shift in animal health toward integrated platforms that combine pharmaceuticals, diagnostics, and equipment. Merck has spent years building out technology capabilities in livestock and companion animals, and TARGAN gives it a hardware and automation layer that many traditional animal health companies still lack. The company can now sell closer to the operating heartbeat of a hatchery, where decisions on vaccination, sorting, labor deployment, and animal welfare are made in real time.
Timing is notable. Acquire.fyi data shows health sector M&A value has reached $76.8 billion year to date, up 91.8% from a year earlier, even as deal volume has slipped. Buyers are writing checks for assets that can reshape delivery models, not just add products. For rivals in poultry health, that raises a harder question. Build competing automation capabilities, partner with equipment specialists, or risk ceding a critical point of control inside the production chain.
Source: Company press release and Acquire.fyi's proprietary data
